Related Experiment Videos
[Acute hepatitis caused by intravenous amiodarone]
J Paniagua Clusells1, R Arcusa Gavalda, F Goma Masip
1Servicio de Cardiología, Hospital de Barcelona SCIAS.
Revista Espanola De Cardiologia
|May 1, 1996
Summary
Intravenous amiodarone can cause acute hepatitis. Close monitoring of liver function is crucial for patients receiving this antiarrhythmic drug to prevent adverse effects.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Amiodarone is a widely used antiarrhythmic medication.
- It is associated with numerous adverse effects.
- Liver injury is a known, albeit infrequent, complication.
Observation:
- A case of acute hepatitis following intravenous amiodarone administration is presented.
- The patient developed liver dysfunction after treatment initiation.
Findings:
- The patient's acute hepatitis was potentially linked to intravenous amiodarone.
- This case highlights a possible etiology for amiodarone-induced liver injury.
Implications:
- Strict monitoring of hepatic function is essential for patients undergoing amiodarone therapy.
- Early detection of liver enzyme abnormalities can guide clinical management.
- Understanding potential drug-induced liver injury is critical for patient safety.